Select your timezone:

Oral Abstract Session
Islet transplant: Clinical Studies in Islet Allo and Auto-Transplantation

Saturday October 28, 2023 | 14:00 to 15:30
Room: Indigo A
Track: N/A


Dr. Bashoo Naziruddin, United States
Total Pancreatectomy with Islet Autotransplantation- Single Center Outcome with Large Cohort of Patients

Mr. Denghao Wu, Australia
The Epidemiology of Hereditary Pancreatitis in Australia and its effect on patient of Total Pancreatectomy with Islet Auto-Transplantation (TPIAT).

Dr. Aye Aye Thant, United Kingdom
Relationship of diabetes technology use with prognosis in people with type 1 diabetes awaiting islet or simultaneous islet kidney transplantation

David A. Baidal, United States
Islet-alone vs. islet-after-kidney transplantation glycemic outcomes: Report from the Collaborative Islet Transplant Registry

Dr. Mehdi Maanaoui, France
Islet transplantation versus insulin alone in type 1 diabetic kidney transplant recipients: a French nationwide study on behalf of the TREPID group

Dr. Michael R Rickels, United States
Beta-cell function and insulin sensitivity with islet transplant alone and islet-after-kidney transplantation for type 1 diabetes in the Clinical Islet Transplantation (CIT) Consortium

Dr. Braulio A Marfil-Garza, Canada
BETA-2 scores overestimate graft function in pancreatic islet transplant recipients with an estimated glomerular filtration rate of <30 ml/min/1.73m2

Prof. Shareen Forbes, United Kingdom
Cost Savings Using The BETA-2 Versus Beta Score In Follow-Up Of Islet Transplant Recipients In The UK Islet Transplant Consortium.

Dr. Piotr Witkowski, United States
Glucose-Dependent Insulin Production and Insulin-Independence in Type 1 Diabetes from Stem Cell-Derived, Fully Differentiated Islet Cells: Updated Data from the VX-880 Clinical Study

Organized by

Supported by

Hosted by

IPITA-IXA-CTRMS Joint Congress • San Diego, CA, USA • October 26-29, 2023
© 2024 IPITA-IXA-CTRMS 2023